Serum level of growth-associated protein 43 is associated with first-episode schizophrenia patients without antipsychotic drugs treatment

HIGHLIGHTS

• who: Libin Xiao and colleagues from the Department of Psychiatry, Nanjing Qinglongshan Mental Hospital, Nanjing, Jiangsu, China Affiliated WuTaiShan Hospital of Medical College of Yangzhou University, Yangzhou, Jiangsu, China have published the research: Serum Level of Growth-Associated Protein 43 Is Associated with First-Episode Schizophrenia Patients without Antipsychotic Drugs Treatment, in the Journal: Computational Intelligence and Neuroscience of 16/05/2022
• what: The Positive and Negative Symptom Scale (PANSS) was used to assess the mental status of patients in the study group (higher score means severer the psychiatric symptoms); the Scale of Social Function . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.